J&J Selloff Exposes Medtech Strain: Is Pharma Carrying Healthcare Stocks?
Johnson & Johnson (J&J) beat third-quarter estimates and raised its gross sales forecast, but shares fell greater than 5% on Tuesday. The J&J selloff facilities on its medical gadget unit, which grew solely 2.5% whereas drug gross sales rose 7.7%. Adjusted earnings of $2.59 per share topped the $2.53 estimate, although they fell 7.5% from…
